Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB vs OFATUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPCORITAMAB vs OFATUMUMAB: Safety Overview

Metric EPCORITAMAB OFATUMUMAB
Total FAERS Reports 2,041 29,913
Deaths Reported 430 695
Death Rate 21.1% 2.3%
Hospitalizations 1,652 3,616
Average Patient Age 67.5 yrs 47.5 yrs
% Female Patients 47.5% 74.9%
Manufacturer Genmab US, Inc. Novartis Pharmaceuticals Corporation
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status N/A Prescription